VIRUS-LIKE PARTICLES; H5N1 VIRUSES; ANTIBODY-RESPONSES; INTRADERMAL VACCINATION; GENETIC IMMUNIZATION; PROTECTIVE IMMUNITY; CHALLENGE; ELECTROPORATION; INFECTION; HUMANS
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, v.81, no.2, pp.239 - 247
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.